Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial

MJC Vader; ASME Schauwvlieghe; FD Verbraak; G Dijkman; JM Hooymans; LI Los; AH Zwinderman; T Peto; CB Hoyng; R van Leeuwen; Hans Vingerling; Y de Jong-Hesse; JJC van Lith-Verhoeven; MG Dijkgraaf; RO Schlingemann

doi:10.1016/j.oret.2019.12.019

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial

MJC Vader, ASME Schauwvlieghe, FD Verbraak, G Dijkman, JM Hooymans, LI Los, AH Zwinderman, T Peto, CB Hoyng, R van Leeuwen, Hans Vingerling, Y de Jong-Hesse, JJC van Lith-Verhoeven, MG Dijkgraaf, RO Schlingemann

Ophthalmology

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

19 Downloads (Pure)

Original language	English
Pages (from-to)	576-587
Number of pages	12
Journal	Ophthalmology Retina
Volume	4
Issue number	6
DOIs	https://doi.org/10.1016/j.oret.2019.12.019
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1016/j.oret.2019.12.019

Repub_125204_O-A.pdfFinal published version, 905 KB

Cite this

Vader, MJC., Schauwvlieghe, ASME., Verbraak, FD., Dijkman, G., Hooymans, JM., Los, LI., Zwinderman, AH., Peto, T., Hoyng, CB., van Leeuwen, R., Vingerling, H., de Jong-Hesse, Y., van Lith-Verhoeven, JJC., Dijkgraaf, MG., & Schlingemann, RO. (2020). Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial. Ophthalmology Retina, 4(6), 576-587. https://doi.org/10.1016/j.oret.2019.12.019

@article{8ba9eb921424437fa6cc758fa1da3fd0,

title = "Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial",

author = "MJC Vader and ASME Schauwvlieghe and FD Verbraak and G Dijkman and JM Hooymans and LI Los and AH Zwinderman and T Peto and CB Hoyng and {van Leeuwen}, R and Hans Vingerling and {de Jong-Hesse}, Y and {van Lith-Verhoeven}, JJC and MG Dijkgraaf and RO Schlingemann",

year = "2020",

doi = "10.1016/j.oret.2019.12.019",

language = "English",

volume = "4",

pages = "576--587",

journal = "Ophthalmology Retina",

issn = "2468-7219",

publisher = "Elsevier Inc.",

number = "6",

}

Vader, MJC, Schauwvlieghe, ASME, Verbraak, FD, Dijkman, G, Hooymans, JM, Los, LI, Zwinderman, AH, Peto, T, Hoyng, CB, van Leeuwen, R, Vingerling, H, de Jong-Hesse, Y, van Lith-Verhoeven, JJC, Dijkgraaf, MG & Schlingemann, RO 2020, 'Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial', Ophthalmology Retina, vol. 4, no. 6, pp. 576-587. https://doi.org/10.1016/j.oret.2019.12.019

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial. / Vader, MJC; Schauwvlieghe, ASME; Verbraak, FD et al.
In: Ophthalmology Retina, Vol. 4, No. 6, 2020, p. 576-587.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial

AU - Vader, MJC

AU - Schauwvlieghe, ASME

AU - Verbraak, FD

AU - Dijkman, G

AU - Hooymans, JM

AU - Los, LI

AU - Zwinderman, AH

AU - Peto, T

AU - Hoyng, CB

AU - van Leeuwen, R

AU - Vingerling, Hans

AU - de Jong-Hesse, Y

AU - van Lith-Verhoeven, JJC

AU - Dijkgraaf, MG

AU - Schlingemann, RO

PY - 2020

Y1 - 2020

U2 - 10.1016/j.oret.2019.12.019

DO - 10.1016/j.oret.2019.12.019

M3 - Article

C2 - 32107188

SN - 2468-7219

VL - 4

SP - 576

EP - 587

JO - Ophthalmology Retina

JF - Ophthalmology Retina

IS - 6

ER -